Pharmaceutical Stocks To Keep An Eye On – February 06th

Eli Lilly and Company, Honeywell International, and Bristol-Myers Squibb are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that are involved in the research, development, manufacture, and sale of drugs and other medical products. These stocks are influenced by factors like drug approvals, regulatory changes, clinical trial results, and market demand for specific medications. Investors in pharmaceutical stocks may consider factors such as product pipeline, patent expirations, and competition within the industry when making investment decisions. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY stock traded up $32.33 during trading hours on Thursday, hitting $874.51. 4,593,939 shares of the company’s stock were exchanged, compared to its average volume of 3,883,681. The firm has a 50 day moving average of $786.57 and a two-hundred day moving average of $843.28. Eli Lilly and Company has a fifty-two week low of $707.02 and a fifty-two week high of $972.53. The firm has a market cap of $830.19 billion, a P/E ratio of 94.42, a P/E/G ratio of 1.72 and a beta of 0.42. The company has a quick ratio of 0.97, a current ratio of 1.27 and a debt-to-equity ratio of 2.03.

Honeywell International (HON)

Honeywell International Inc. engages in the aerospace technologies, building automation, energy and sustainable solutions, and industrial automation businesses in the United States, Europe, and internationally. The company’s Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; and thermal systems, as well as wireless connectivity services.

NASDAQ:HON traded down $12.42 during trading hours on Thursday, reaching $209.93. 7,424,062 shares of the company were exchanged, compared to its average volume of 3,694,732. The stock’s 50-day moving average is $225.46 and its 200-day moving average is $215.23. Honeywell International has a twelve month low of $189.75 and a twelve month high of $242.77. The firm has a market cap of $136.51 billion, a PE ratio of 24.23, a price-to-earnings-growth ratio of 2.57 and a beta of 1.05. The company has a current ratio of 1.44, a quick ratio of 1.12 and a debt-to-equity ratio of 1.44.

Bristol-Myers Squibb (BMY)

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia.

BMY stock traded down $2.16 during trading on Thursday, hitting $57.55. The stock had a trading volume of 16,201,969 shares, compared to its average volume of 10,354,815. Bristol-Myers Squibb has a twelve month low of $39.35 and a twelve month high of $61.10. The company’s 50-day moving average price is $57.65 and its two-hundred day moving average price is $53.63. The company has a debt-to-equity ratio of 2.83, a current ratio of 1.24 and a quick ratio of 1.09. The stock has a market capitalization of $116.72 billion, a P/E ratio of -16.07, a PEG ratio of 2.10 and a beta of 0.45.